Pompe Disease Clinical Trials

8 recruiting

Pompe Disease Trials at a Glance

14 actively recruiting trials for pompe disease are listed on ClinicalTrialsFinder across 6 cities in 47 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Durham, Philadelphia, and New York. Lead sponsors running pompe disease studies include Duke University, Genzyme, a Sanofi Company, and Assistance Publique Hopitaux De Marseille.

Browse pompe disease trials by phase

Treatments under study

About Pompe Disease Clinical Trials

Looking for clinical trials for Pompe Disease? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pompe Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pompe Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 2

Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

Pompe Disease
Shionogi45 enrolled28 locationsNCT07123155
Recruiting

Pompe Disease Registry Protocol

Pompe DiseaseGlycogen Storage Disease Type II
Genzyme, a Sanofi Company2,000 enrolled272 locationsNCT00231400
Recruiting

Pompe Pregnancy Sub-Registry

Pompe Disease (Late-onset)Glycogen Storage Disease Type II (GSD-II)Glycogenesis 2 Acid Maltase Deficiency
Genzyme, a Sanofi Company20 enrolled35 locationsNCT00567073
Recruiting
Phase 1Phase 2

A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late Onset Pompe Disease (PROGRESS-GT LOPD)

Pompe Disease (Late-onset)
AskBio Inc12 enrolled10 locationsNCT07282847
Recruiting

Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

Pompe Disease
Duke University400 enrolled1 locationNCT01665326
Recruiting
Not Applicable

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Myasthenia GravisAmyotrophic Lateral SclerosisNeuromuscular Diseases (NMD)+15 more
University of Missouri-Columbia50 enrolled1 locationNCT07478172
Recruiting

A Global Prospective Observational Registry of Patients With Pompe Disease

Pompe Disease
Amicus Therapeutics500 enrolled41 locationsNCT06121011
Recruiting

Cognitive and Neurological Pathologies in Pompe Disease

Pompe Disease
Duke University45 enrolled1 locationNCT04639336
Recruiting

Avalglucosidase Alfa Pregnancy Study

PregnancyPompe Disease
Sanofi100 enrolled1 locationNCT05734521
Recruiting
Not Applicable

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

Myasthenia GravisHuntington DiseaseNeuromuscular Diseases+9 more
Centre Hospitalier Universitaire de Liege300 enrolled1 locationNCT07136844
Recruiting
Phase 1Phase 2

Evaluation of the Safety and Efficacy of Late-onset Pompe Disease Gene Therapy Drug

Pompe Disease (Late-onset)
GeneCradle Inc33 enrolled1 locationNCT06391736
Recruiting
Not Applicable

Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases

Muscular Dystrophy, DuchenneMuscular Dystrophy, BeckerCongenital Myopathy+2 more
Assistance Publique Hopitaux De Marseille50 enrolled1 locationNCT06833489
Recruiting

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Myasthenia GravisAmyloidosisAlpha-Thalassemia+14 more
xCures1,000 enrolled1 locationNCT06539169
Recruiting

A Long-term Study for the Outcome of Pompe Disease

Pompe Disease
National Taiwan University Hospital50 enrolled1 locationNCT02399748